Related Experiment Video

Updated: Jul 17, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

Percutaneous mitral balloon valvotomy

Mohamed Eid Fawzy1

  • 1Adult Cardiology, King Faisal Heart Institute, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. fawzy100@hotmail.com

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|January 27, 2007
PubMed

Insights

Percutaneous mitral balloon valvotomy (PMBV) is a safe and effective treatment for severe mitral stenosis. Favorable mitral morphology significantly improves long-term outcomes and reduces restenosis rates.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Percutaneous mitral balloon valvotomy (PMBV) was developed in 1984 as an alternative to surgical mitral commissurotomy.
  • PMBV is the preferred treatment for severe, pliable rheumatic mitral stenosis (MS).
  • Patient selection and procedural experience have improved PMBV outcomes and reduced complication rates.

Purpose of the Study:

  • To review the efficacy and safety of PMBV for severe mitral stenosis.
  • To analyze complication rates, restenosis rates, and long-term survival after PMBV.
  • To discuss the impact of PMBV on associated cardiac conditions and its application in specific patient groups.

Main Methods:

  • Review of existing literature and reported complication rates.
  • Analysis of long-term follow-up data, including restenosis-free and event-free survival.
  • Evaluation of hemodynamic results and effects on secondary cardiac conditions.

Main Results:

  • PMBV exhibits low complication rates: mortality (0-0.5%), cerebral accident (0.5-1%), and MR requiring surgery (1.6-3%).
  • Restenosis rates vary (4-70%), but favorable mitral morphology is associated with significantly higher 10 and 15-year restenosis-free survival (85-65%) and event-free survival (88-66%).
  • PMBV demonstrates comparable hemodynamic results to surgical commissurotomy.

Conclusions:

  • PMBV is a safe and effective treatment for severe mitral stenosis with favorable long-term outcomes.
  • Patient selection, particularly favorable mitral morphology, is crucial for optimizing results and minimizing restenosis.
  • The review addresses PMBV's effects on pulmonary hypertension, tricuspid regurgitation, and its use in children, pregnancy, and restenosis management.

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat07:42

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat

Published on: May 19, 2020

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...